Science Explorer Back to mapMap
Discussion
Researcher · Roche (Switzerland) · Switzerland

Michael Klaus

Michael Klaus publishes mostly in Organic Chemistry, Molecular Biology and Finance, on topics such as European Monetary and Fiscal Policies, Retinoids in leukemia and cellular processes and Estrogen and related hormone effects.

OpenAlex
World rank
#3,870,453
of 7,710,434 ranked researchers
Rank in Switzerland
#54,327
of 80,918
Works
28
Citations
729
Citations per work
26.0
h-index
11
i10-index 12Top 57% in Organic Chemistry
Michael Klaus

What does Michael Klaus research?

Michael Klaus's work is mostly in Biochemistry, Genetics and Molecular Biology (23%), Chemistry (22%), Economics, Econometrics and Finance (12%).

Everything else: 11 works · 39.3% of their workPhysical Sciences: 7 works · 26.0% of their workChemistry: 6 works · 21.7% of their workOrganic Chemistry: 4 works · 15.9% of their workSpectroscopy: 2 works · 5.8% of their workEnvironmental Science: 1 works · 4.3% of their workGlobal and Planetary Change: 1 works · 4.3% of their workLife Sciences: 6 works · 23.1% of their workBiochemistry, Genetics and Molecular Biology: 6 works · 23.1% of their workMolecular Biology: 4 works · 15.9% of their workGenetics: 2 works · 7.2% of their workSocial Sciences: 3 works · 11.6% of their workEconomics, Econometrics and Finance: 3 works · 11.6% of their workFinance: 3 works · 11.6% of their workTHEIR WORKMichael Klaus28works
Life Sciences23%Physical Sciences26%Social Sciences12%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
  1. Everything else1139.3%
    1. Chemistry621.7%
    2. Environmental Science14.3%
    1. Biochemistry, Genetics and Molecular Biology623.1%
    1. Economics, Econometrics and Finance311.6%
  1. 1Organic Chemistry16% of their works
  2. 2Molecular Biology16% of their works
  3. 3Finance12% of their works
  4. 4Genetics7% of their works
  5. 5Spectroscopy6% of their works
  6. 6Global and Planetary Change4% of their works

Research topics

Which keywords describe Michael Klaus's research?

The keywords of their largest research topics: Nuclear Receptors, ECB's Rescue Facility, TARGET2 Balances, Acute Promyelocytic Leukemia, Retinoic Acid, Estrogen, Medicinal Chemistry and Receptor.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Nuclear Receptors112 topics
  2. ECB's Rescue Facility71 topic
  3. TARGET2 Balances71 topic
  4. Acute Promyelocytic Leukemia61 topic
  5. Retinoic Acid61 topic
  6. Estrogen51 topic
  7. Medicinal Chemistry52 topics
  8. Receptor51 topic
  9. Synthesis52 topics
  10. Antioxidants42 topics
  11. Amination31 topic
  12. Catalytic31 topic
  13. Chromones21 topic
  14. Flavonoids21 topic
  15. Lipid Peroxidation21 topic
  16. Organic Chemistry21 topic
  17. Oxidative Stress21 topic
  18. Reactivity21 topic
  19. Exposure11 topic
  20. Pesticides11 topic

Where does Michael Klaus work?

Michael Klaus's main affiliation in the publication record is Roche (Switzerland), Switzerland.

How many publications and citations does Michael Klaus have?

OpenAlex counts 28 works and 729 citations for Michael Klaus, an h-index of 11, ranking #3,870,453 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Michael Klaus

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michael Klaus. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.